Cargando…

Human herpesvirus type 8 variants in Kaposi's sarcoma before and after AIDS era

Detalles Bibliográficos
Autores principales:	Tornesello, Maria Lina, Biryahwaho, Benon, Downing, Robert, Hatzakis, Angelo, Alessi, Elvio, Cusini, Marco, Ruocco, Vincenzo, Loquercio, Giovanna, Katongole-Mbidde, Edward, Buonaguro, Luigi, Buonaguro, Franco M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002696/ http://dx.doi.org/10.1186/1750-9378-5-S1-A37

Ejemplares similares

Effect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcoma
por: Starita, Noemy, et al.
Publicado: (2017)

Kaposi’s sarcoma: Etiology and pathogenesis, inducing factors, causal associations, and treatments: Facts and controversies
por: Ruocco, Eleonora, et al.
Publicado: (2013)

A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis
por: Chang, Joanne T, et al.
Publicado: (2013)

Evaluating the role of human papillomaviruses in conjunctival neoplasia
por: Tornesello, M L, et al.
Publicado: (2006)

Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda
por: Johnston, Christine, et al.
Publicado: (2009)

Identification of Human Herpesvirus 8 Sequences in Conjunctiva Intraepithelial Neoplasia and Squamous Cell Carcinoma of Ugandan Patients
por: Starita, Noemy, et al.
Publicado: (2015)

Kaposi sarcoma herpesvirus pathogenesis
por: Mariggiò, Giuseppe, et al.
Publicado: (2017)

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
por: Newton, R, et al.
Publicado: (2003)

Kaposi’s Sarcoma Herpesvirus Genome Persistence
por: Juillard, Franceline, et al.
Publicado: (2016)

Kaposi's sarcoma-associated herpesvirus at 27
por: Gaglia, Marta Maria
Publicado: (2021)

Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors.
por: Kang, G. H., et al.
Publicado: (1998)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017)

HPV monitoring in kidney transplanted patients
por: Buonaguro, Franco M, et al.
Publicado: (2012)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

The XIX century smallpox prevention in Naples and the risk of transmission of human blood-related pathogens
por: Buonaguro, Franco Maria, et al.
Publicado: (2015)

Using Media to Promote Public Awareness of Early Detection of Kaposi's Sarcoma in Africa
por: Laker-Oketta, Miriam, et al.
Publicado: (2020)

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues
por: Sun, Rui, et al.
Publicado: (2017)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
por: Jary, Aude, et al.
Publicado: (2021)

Pathology of Kaposi’s Sarcoma-Associated Herpesvirus Infection
por: Fukumoto, Hitomi, et al.
Publicado: (2011)

The Ubiquitin System and Kaposi’s Sarcoma-Associated Herpesvirus
por: Ashizawa, Akira, et al.
Publicado: (2012)

Kaposi’s Sarcoma-Associated Herpesvirus microRNAs
por: Gottwein, Eva
Publicado: (2012)

For the Future Studies of Kaposi’s Sarcoma-Associated Herpesvirus
por: Ueda, Keiji
Publicado: (2012)

Epigenetic diversity of Kaposi’s sarcoma–associated herpesvirus
por: Darst, Russell P., et al.
Publicado: (2013)

The Chromatin Landscape of Kaposi’s Sarcoma-Associated Herpesvirus
por: Toth, Zsolt, et al.
Publicado: (2013)

Epidemiology and Transmission of Kaposi’s Sarcoma-Associated Herpesvirus
por: Minhas, Veenu, et al.
Publicado: (2014)

Insight into the Epigenetics of Kaposi’s Sarcoma-Associated Herpesvirus
por: Srivastava, Anusha, et al.
Publicado: (2023)

Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2018)

Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)

Epstein-barr virus and kaposi's sarcoma herpesvirus/human herpesvirus 8
Publicado: (1997)

Tegument Proteins of Kaposi’s Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses
por: Sathish, Narayanan, et al.
Publicado: (2012)

Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
por: Dedicoat, M, et al.
Publicado: (2003)

Genotypic Analysis of Kaposi’s Sarcoma-Associated Herpesvirus from Patients with Kaposi’s Sarcoma in Xinjiang, China
por: Ouyang, Xinxing, et al.
Publicado: (2014)

Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma
por: Santiago, Jan Clement, et al.
Publicado: (2021)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

Innate immunity and hepatitis C virus infection: a microarray’s view
por: Buonaguro, Luigi, et al.
Publicado: (2012)

Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections
por: Tornesello, Maria Lina, et al.
Publicado: (2016)

Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
por: Starita, Noemy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7evt2ga8lbso7e4382o1dkqgaq